Company Filing History:
2 out of 17 
1 out of 111 Years Active: 1995-1998
Title: The Innovative Contributions of John Blankenship
Introduction
John Blankenship is a notable inventor based in Santa Clara, CA. He has made significant contributions to the field of medical technology, particularly in the area of blood treatment. With a total of 3 patents, his work focuses on improving patient outcomes through innovative methods.
Latest Patents
One of John Blankenship's latest patents involves the removal of selected factors from whole blood or its components. This invention provides a composition, device, and method for the removal of selected factors, such as cytokines or pharmaceuticals, from substances like whole blood or plasma. The invention is particularly advantageous for treating or preventing septic shock syndrome and other conditions characterized by elevated cytokine levels in patients. By contacting the patient's whole blood with a composition that includes silica and a surface treatment material, such as heparin or preferably human serum albumin (HSA), the treatment effectively lowers the cytokine concentration in the blood. Additionally, this method allows for the removal of pharmaceuticals from an individual's whole blood or plasma, which can be crucial in cases of drug overdosage.
Career Highlights
Throughout his career, John Blankenship has worked with several prominent companies, including Applied Immunesciences, Inc. and Rhone-Poulenc Rorer Pharmaceuticals Inc. His experience in these organizations has contributed to his expertise in the field of medical innovations.
Collaborations
John has collaborated with notable professionals in his field, including Thomas B. Okarma and Abraham T. Lin. These collaborations have likely enriched his work and led to further advancements in his inventions.
Conclusion
John Blankenship's innovative contributions to medical technology demonstrate his commitment to improving patient care through scientific advancements. His patents reflect a deep understanding of the complexities of blood treatment and the potential for innovative solutions in healthcare.